WHAT’S AT STAKE IN THE SUPREME COURT’S MIFEPRISTONE CASE? (Factsheet)

This summer, the U.S. Supreme Court is expected to rule in FDA v Alliance for Hippocratic Medicine, which concerns access to one of two pills typically used together to provide medication abortion care. The outcome of this case threatens to place abortion care further out of reach for everyone in the United States, especially those working to make ends meet, rural folks, immigrants, and Black, Indigenous, and people of color.